新巴:一名駕駛23號線巴士車長確診新冠肺炎 曾駕駛四輛巴士
新創建(00659.HK)旗下新巴公布,昨晚上接獲衛生署通知,一名新巴駕駛23號線)的車長初步確診新型冠狀病毒肺炎。該名車長於7月12日休假,7月13日至14日上班。車長7月15日休假期間出現病徵後往診所求醫,7月16日病假,晚上已入院接受隔離及進一步檢測,今早(17日)確診,現時情況穩定。
確診車長於7月13日至14日曾駕駛的4輛巴士(車身編號3828、4062、4072、4076)昨晚已返廠,以1:49稀釋漂白水進行徹底消毒及清潔,包括冷氣隔塵網。北角碼頭巴士總站、蒲飛路巴士總站的站長室及員工休息室亦於昨晚進行徹底消毒清潔。
公司已安排7月13日至14日也曾駕駛上述4輛巴士的車長,以及曾與確診車長一起用膳的車長暫時停工,並進行新型冠狀病毒測試。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.